Addus HomeCare Corporation (NASDAQ:ADUS) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Key Points

• Addus HomeCare received a “Moderate Buy” consensus rating from 11 analysts, including seven buys and one strong buy. The average 12-month price target is $130.88.
• The company beat quarterly expectations, reporting $1.73 EPS versus the $1.70 consensus and revenue of $377.41 million, up 8% year over year.
• ADUS opened at $120.81, near its 52-week high of $124.43, while institutional investors own a substantial 95.35% stake in the company.

Shares of Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eleven brokerages that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $130.8750.

A number of research firms recently commented on ADUS. Royal Bank Of Canada boosted their target price on Addus HomeCare from $130.00 to $134.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 5th. Citigroup restated a "market outperform" rating on shares of Addus HomeCare in a report on Friday, July 24th. Barclays lifted their price objective on Addus HomeCare from $92.00 to $96.00 and gave the stock an "underweight" rating in a research note on Wednesday, July 8th. Weiss Ratings upgraded Addus HomeCare from a "hold (c-)" rating to a "hold (c)" rating in a research report on Thursday, July 9th. Finally, Citizens Jmp reissued a "market outperform" rating and issued a $142.00 target price on shares of Addus HomeCare in a report on Monday, May 18th.

Addus HomeCare Stock Performance

ADUS stock opened at $120.81 on Monday. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.69 and a quick ratio of 1.69. Addus HomeCare has a 1-year low of $87.95 and a 1-year high of $124.43. The business has a 50 day simple moving average of $109.47 and a two-hundred day simple moving average of $102.48. The company has a market capitalization of $2.26 billion, a price-to-earnings ratio of 21.19, a PEG ratio of 1.62 and a beta of 0.87.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings data on Monday, August 3rd. The company reported $1.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.70 by $0.03. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The firm had revenue of $377.41 million for the quarter, compared to analysts' expectations of $376.24 million. During the same quarter last year, the business posted $1.49 earnings per share. The company's revenue for the quarter was up 8.0% compared to the same quarter last year. Research analysts anticipate that Addus HomeCare will post 6.29 EPS for the current fiscal year.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of the stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the transaction, the insider owned 44,371 shares in the company, valued at $4,160,668.67. This trade represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is currently owned by insiders.

Institutional Trading of Addus HomeCare

Several hedge funds have recently made changes to their positions in ADUS. Royal Bank of Canada grew its position in Addus HomeCare by 24.3% in the first quarter. Royal Bank of Canada now owns 6,899 shares of the company's stock worth $682,000 after acquiring an additional 1,347 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Addus HomeCare by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company's stock valued at $1,026,000 after purchasing an additional 459 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Addus HomeCare by 6.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company's stock valued at $5,111,000 after purchasing an additional 2,952 shares during the last quarter. Jane Street Group LLC lifted its stake in shares of Addus HomeCare by 387.6% in the 1st quarter. Jane Street Group LLC now owns 11,045 shares of the company's stock valued at $1,092,000 after purchasing an additional 8,780 shares during the last quarter. Finally, Intech Investment Management LLC boosted its holdings in shares of Addus HomeCare by 44.7% in the 1st quarter. Intech Investment Management LLC now owns 14,362 shares of the company's stock worth $1,420,000 after purchasing an additional 4,439 shares during the period. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

About Addus HomeCare

Addus HomeCare NASDAQ: ADUS is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients' independence and quality of life.

The company's core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source